Insiders Updates Examining the Potential Price Growth of Verona Pharma Plc ADR (VRNA) In a filing, Verona Pharma Plc ADR revealed its General Counsel Fisher Andrew unloaded Company’s shares for reported $0.92 million
Stock Earnings Decline in VRNA’s short interest indicates Bullish sentiment The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Analysts Viewpoint Verona Pharma Plc ADR [VRNA] stock was sold by Fisher Andrew at the price of US$0.92 million Verona Pharma Plc ADR’s recently made public that its General Counsel Fisher Andrew unloaded Company’s shares for reported $0.92 million
Analysts Viewpoint 0 analysts rank VRNA stock as an Overweight Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its